Many thanks RNClarke for making time to attend the EGM, asking the key questions and reporting back.
I continue to be impressed with management, who know how to build new medical tech businesses from scratch and manage shareholder expectations. Confidence in the tech and it’s usefulness will continue to build as the DSA consultants roll it out. We just need some intial commercial contracts from a few aged care providers and the share price should really gain some traction.
EPT Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
